Intensive haemodialysis using PMMA dialyser does not increase renal response rate in multiple myeloma patients with

Laurent Hudier1, Olivier Decaux2,3,4,5,6,7,8,9,10,11, Atmann Haddj-Elmrabet3

  • 1Centre hospitalier Broussais, Service de Néphrologie-Hémodialyse, Saint-Malo, France.

Abstract

Insights

Intensive haemodialysis (IHD) did not show a renal benefit over standard haemodialysis (SHD) for multiple myeloma (MM) patients with acute kidney injury. Achieving a hematologic response to chemotherapy was crucial for kidney recovery and improved patient survival.

Area of Science:

  • Nephrology
  • Hematology
  • Oncology

Background:

  • Multiple myeloma (MM) patients with acute kidney injury (AKI) may benefit from intensive hemodialysis (IHD) for rapid reduction of serum free light chains.
  • IHD alongside bortezomib-based chemotherapy could potentially improve renal outcomes and survival in MM patients.

Purpose of the Study:

  • To compare the efficacy of IHD versus standard hemodialysis (SHD) in MM patients with dialysis-dependent AKI undergoing bortezomib-based chemotherapy.
  • To evaluate the renal recovery rate as the primary outcome measure.

Main Methods:

  • Retrospective, multi-center study involving 41 MM patients with dialysis-dependent AKI.
  • Patients were divided into two groups: IHD (n=21) and SHD (n=20).
  • Primary endpoint was dialysis independence at 3 months.

Main Results:

  • No significant difference in dialysis independence at 3 months between IHD (38.1%) and SHD (35%) groups (P=1).
  • A significant association was observed between hematologic response to chemotherapy and dialysis independence (56% vs 6.3%, P=0.002).
  • The type of dialysis did not influence renal recovery in this cohort.

Conclusions:

  • Intensive hemodialysis (IHD) did not demonstrate a clear renal benefit compared to standard hemodialysis (SHD) in multiple myeloma patients with myeloma cast nephropathy.
  • Hematologic response to chemotherapy is a critical factor for renal recovery and overall prognosis in these patients.
  • Further research may be needed to explore optimal dialysis strategies in MM-related AKI.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
804
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.2K
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
492
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
365
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
984
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
1.2K